GlaxoSmithKline is a science-led global healthcare company on a mission to help people do more, feel better and live longer. The Company has three world-leading businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. GlaxoSmithKline manufactures products for major disease areas such as asthma, cancer, infections, diabetes and mental health. 

Company Growth (employees)
Brentford, GB
Size (employees)
99,827 (est)
GlaxoSmithKline was founded in 2001 and is headquartered in Brentford, GB

Key People/Management at GlaxoSmithKline

Simon Dingemans

Simon Dingemans

Chief Financial Officer
David Redfern

David Redfern

Chief Strategy Officer
Roger Connor

Roger Connor

President, Global Manufacturing & Supply
Luc Debruyne

Luc Debruyne

President, Global Vaccines
Nick Hirons

Nick Hirons

Senior Vice President, Global Ethics and Compliance
Brian McNamara

Brian McNamara

CEO, GSK Consumer Healthcare
Luke Miels

Luke Miels

President, Global Pharmaceuticals
Karenann Terrell

Karenann Terrell

Chief Digital & Technology Officer
Claire Thomas

Claire Thomas

Senior Vice President, Human Resources
Phil Thomson

Phil Thomson

President, Global Affairs
Patrick Vallance

Patrick Vallance

Outgoing President, R&D
Emma Walmsley

Emma Walmsley

Chief Executive Officer of GSK
Hal Barron

Hal Barron

Chief Scientific Officer and President, R&D
Dan Troy

Dan Troy

Senior Vice President & General Counsel

GlaxoSmithKline Office Locations

GlaxoSmithKline has offices in Brentford, Tirana, Boudouaou Est, Buenos Aires and in 145 other locations
Tirana, AL
Str. Barrikadave No. 118
Boudouaou Est, DZ
Boumerdes, 35 400
Yerevan, AM
7 Baghramian Avenue, Flat 3
Boronia, AU
1061 Mountain Highway
Wien, AT
Euro Plaza, Gebäude I, 4. Stock, Wagenseilgasse 3
Baku, AZ
96 Nizami Street
Show all (149)

GlaxoSmithKline Financials and Metrics

GlaxoSmithKline Financials

GlaxoSmithKline's revenue was reported to be £27.9 b in FY, 2016 which is a 17% increase from the previous period.

Revenue (FY, 2016)

27.9 b

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

18.6 b

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

1.1 b

Market capitalization (31-Oct-2017)

89 b

Closing share price (31-Oct-2017)


Cash (31-Dec-2016)

4.9 b
GlaxoSmithKline's current market capitalization is $89 b.
GBPFY, 2013FY, 2014FY, 2015FY, 2016


26.5 b23 b23.9 b27.9 b

Revenue growth, %


Cost of goods sold

8.6 b7.3 b8.9 b9.3 b

Gross profit

17.9 b15.7 b15.1 b18.6 b
GBPFY, 2013FY, 2014FY, 2015FY, 2016


5.5 b4.3 b5.8 b4.9 b

Accounts Receivable

4 b3.6 b3.9 b4.7 b

Current Assets

15.2 b14.7 b16.6 b16.7 b


13.4 b13.9 b15 b17.6 b
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Cash From Operating Activities

2.6 b5.2 b7.2 b6.5 b

Cash From Financing Activities

(6.3 b)(5.4 b)(7.1 b)(6.4 b)

Income Taxes Paid

(1 b)(137 m)(2.2 b)(877 m)
GBPY, 2016


279.4 k

Financial Leverage

52.6 x
Show all financial metrics

GlaxoSmithKline Operating Metrics

GlaxoSmithKline's Unique Visitors was reported to be 1.8 m in FY, 2016
FY, 2015FY, 2016FY, 2017



Manufacturing Facilities




New Product Launches

Show all operating metrics

GlaxoSmithKline Market Value History

GlaxoSmithKline Revenue Breakdown

GlaxoSmithKline Median Salaries

Source: 173 public H-1B filings from GlaxoSmithKline

GlaxoSmithKline's Web-traffic and Trends

GlaxoSmithKline Online and Social Media Presence

GlaxoSmithKline Company Life and Culture

You may also be interested in